Literature DB >> 15986341

How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?

Désirée van der Heijde1, Robert Landewé, Sjef van der Linden.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15986341     DOI： 10.1002/art.21133

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  14 in total

Review 1.  Mechanisms of pathologic new bone formation.

Authors:  Kurt de Vlam; Rik J U Lories; Frank P Luyten
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 2.  Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?

Authors:  M M Ward
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

3.  Radiologic parameters of ankylosing spondylitis patients treated with anti-TNF-α versus nonsteroidal anti-inflammatory drugs and sulfasalazine.

Authors:  Seung Min Son; Sung Hoon Choi; Jong Ki Shin; Tae Sik Goh; Jung Sub Lee
Journal:  Eur Spine J       Date:  2019-02-11       Impact factor: 3.134

Review 4.  [Outcome parameters in ankylosing spondylitis].

Authors:  H Haibel; M Rudwaleit; J Sieper
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 5.  Cost effectiveness of therapeutic interventions in ankylosing spondylitis: a critical and systematic review.

Authors:  Cécile Gaujoux-Viala; Bruno Fautrel
Journal:  Pharmacoeconomics       Date:  2012-12-01       Impact factor: 4.981

Review 6.  Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics.

Authors:  Heiner Appel; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 7.  Etanercept: a review of its use in the management of ankylosing spondylitis and psoriatic arthritis.

Authors:  Sheridan M Hoy; Lesley J Scott
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Braun; R van den Berg; X Baraliakos; H Boehm; R Burgos-Vargas; E Collantes-Estevez; H Dagfinrud; B Dijkmans; M Dougados; P Emery; P Geher; M Hammoudeh; R D Inman; M Jongkees; M A Khan; U Kiltz; Tk Kvien; M Leirisalo-Repo; W P Maksymowych; I Olivieri; K Pavelka; J Sieper; E Stanislawska-Biernat; D Wendling; S Ozgocmen; C van Drogen; Bj van Royen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103

9.  Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

Authors:  Désirée van der Heijde; David Salonen; Barbara N Weissman; Robert Landewé; Walter P Maksymowych; Hartmut Kupper; Shaila Ballal; Eric Gibson; Robert Wong
Journal:  Arthritis Res Ther       Date:  2009-08-24       Impact factor: 5.156

10.  Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the Clinician.

Authors:  Laura C Coates; Helena Marzo-Ortega; Alexander N Bennett; Paul Emery
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.